Skip to content

H.R. 3731 · 119th Congress (2025–2027)

Small Biotech Innovation Act

To amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exception from the Medicare drug price negotiation program.

CRS summary not yet available.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 3731’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. August Pfluger (R-TX-11)
Cosponsors
4 cosponsors

1 original · 3 later

  1. Rep. David Kustoff (R-TN-8)· Original · Jun 4, 2025
  2. Rep. Claudia Tenney (R-NY-24)· Later · Dec 19, 2025
  3. Rep. Lateefah Simon (D-CA-12)· Later · Apr 14, 2026
  4. Rep. Nathaniel Moran (R-TX-1)· Later · Jul 21, 2026
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Jun 4, 2025
  2. HouseWays and MeansReferred Jun 4, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Small Biotech Innovation Act

    Display title, Short title · Introduced in House

  2. To amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exception from the Medicare drug price negotiation program.

    Official title · Introduced in House